Patient | 1 | 2 | 3 | 4 | 5 | ||||
---|---|---|---|---|---|---|---|---|---|
Pre-KT | Post-KT | 1st post-KT biopsy | 2nd post-KT biopsy | 3rd post-KT biopsy | Post-KT | Post-KT | 1st post-KT biopsy | 2nd post-KT biopsy | |
Sex/Age | M/38 | M/41 | M/44 | M/45 | M/48 | F/30 | M/51 | M/51 | M/53 |
Cause of ERSD | MPGN (PGNMID) | MPGN | Unknown | Unknown | MPGN | ||||
Transplant type | DCD | DCD | DCD | Living-related donor | DCD | ||||
Immunosuppression protocol | Pre + MMF + CsA | Pre + MMF + FK506 | Pre + MMF + FK506 | Pre + MMF + FK506 | Pre + MMF + FK506 | ||||
PRA | I-/II- | I-/II- | I-/II- | I-/II- | I+/II- | I-/II+ | I-/II- | I-/II- | |
Time interval from KT to PGNMID | 19 months | 15 monthsa | 52 months | 10.5 months | 11 months | 5 months | 33 months | ||
Scr at biopsy (mg/dL) | 9.2 | 0.77 | 1.26 | 1.24 | 3.05 | 1.2 | 1.67 | 1.88 | 1.33 |
Proteinuria at biopsy (g/24 h) | 4+ | 2.21 | 2+ | 6.09 | 0.66 | 5.5 | 1.3 | 37.03 | |
Hematuria at biopsy | 2+ | 3+ | ND | ND | 2+ | 3+ | 4+ | 2+ | 3+ |
Urine C3 (mg/dL) | 32.0 | 8.2 | ND | ND | ND | ND | 3 | ND | ND |
Serum C3/C4 | ND | Normal | ND | ND | ND | Normal | Normal | Normal | Normal |
Serum kappa/lambda | ND | ND | ND | Normal | Normal | 4.2/2.51 mg/L | 86.51/68.8 mg/L | Normal | ND |
Cryoglobulin | Negative | Negative | ND | Negative | Negative | Negative | Negative | Negative | ND |
C3NeF | Negative | Negative | ND | ND | ND | Negative | Negative | Negative | ND |
CFH | ND | ND | ND | ND | ND | Normal | Normal | Negative | ND |
CFH antibody | ND | Negative | ND | ND | ND | Negative | ND | Negative | ND |
HBV/HCV/HIV | Negative | Negative | Negative | Negative | Negative | Negative | Negative | HCV+ | Negative |
Serum M spike | ND | ND | ND | Negative | Negative | Negative | Negative | Negative | Negative |
Bone marrow aspirate | ND | ND | ND | ND | ND | Negative | Negative | Negative | Negative |